Cronos hits 1m product milestone as revenues continue to rise

The Cannabis Observer ·
Cronos hits 1m product milestone as revenues continue to rise

Cronos Australia has reported unaudited revenue of A$10.7 million in November as the company sold its one millionth product through the CanView platform.

Chief executive Rodney Cocks said he was "proud to recognise such a significant milestone" just two-and-a-half years after launching CanView.

"Importantly, given the continued growth of unit sales, we anticipate that the second million units should be sold through the platform before the end of calendar 2023," he said.

The landmark figure came as Cronos reported another month of revenues in excess of $10m.

Nearly 215,000 units were sold during the first quarter of FY23, the company said, with revenue for the first five months of the financial year close to $50m.

It sold 86,000 products in November, taking the total to almost 380,000 in FY23.

"Based on the revenues generated in November, we remain confident of our earlier forecast that our total revenues for FY23 will exceed $100 million, up from $67 million in FY22," Cocks said.

"Based on the unaudited November numbers, total revenues now annualise at nearly $130m and unit sales at more than 1 million.

"This success demonstrates the scalability of the company's business model which we believe will continue to deliver growth and further shareholder value."

Related Articles